{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:30:54Z","timestamp":1775809854173,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.antiviral.2019.104702","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T18:00:09Z","timestamp":1579716009000},"page":"104702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies"],"prefix":"10.1016","volume":"174","author":[{"given":"Marko","family":"Zivcec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R.","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104702_bib1","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model","volume":"84","author":"Bente","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","article-title":"Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice","volume":"91","author":"Bereczky","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib3","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1016\/j.vaccine.2011.04.043","article-title":"A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-\/-) mice upon lethal virus challenge","volume":"29","author":"Boshra","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.104702_bib4","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib5","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1099\/vir.0.81767-0","article-title":"Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice","volume":"87","author":"Boyd","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1743-422X-8-300","article-title":"A STAT-1 knockout mouse model for Machupo virus pathogenesis","volume":"8","author":"Bradfute","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2019.104702_bib7","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1093\/infdis\/jiv215","article-title":"Interferon \u03b1\/\u03b2 receptor\u2013deficient mice as a model for Ebola virus disease","volume":"212","author":"Brannan","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib8","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1099\/0022-1317-82-6-1365","article-title":"The role of the Type I interferon response in the resistance of mice to filovirus infection","volume":"82","author":"Bray","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091516","article-title":"A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model","volume":"9","author":"Buttigieg","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104702_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003579","article-title":"Immunization of knock-out \u03b1\/\u03b2 interferon receptor mice against high lethal dose of crimean-Congo hemorrhagic fever virus with a cell culture based vaccine","volume":"9","author":"Canakoglu","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4269\/ajtmh.1970.19.846","article-title":"Congo virus from domestic livestock, African hedgehog, and arthropods in Nigeria","volume":"19","author":"Causey","year":"1970","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2019.104702_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104703","article-title":"The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: potential effects on adaptive immunity and response to vaccination","author":"Clarke","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104702_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v11020137","article-title":"Filovirus virulence in interferon \u03b1\/\u03b2 and \u03b3 double knockout mice, and treatment with favipiravir","volume":"11","author":"Comer","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104702_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/21645515.2015.1078045","article-title":"A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease","volume":"12","author":"Dowall","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2019.104702_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1099\/vir.0.038455-0","article-title":"Hazara virus infection is lethal for adult type I interferon receptor-knockout mice and may act as a surrogate for infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus","volume":"93","author":"Dowall","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156637","article-title":"Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses","volume":"11","author":"Dowall","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104702_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.virol.2005.09.020","article-title":"Replication-defective viruses as vaccines and vaccine vectors","volume":"344","author":"Dudek","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104702_bib20","first-page":"1","article-title":"Co-delivery effect of CD24 on the immunogenicity and lethal challenge protection of a DNA vector expressing nucleocapsid protein of crimean Congo hemorrhagic fever virus","volume":"11","author":"Farzani","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104702_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/v11030237","article-title":"Bovine herpesvirus type 4 (BoHV-4) vector delivering nucleocapsid protein of crimean-Congo hemorrhagic fever virus induces comparable protective immunity against lethal challenge in IFN\u03b1\/\u03b2\/\u03b3r-\/- mice models","volume":"11","author":"Farzani","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104702_bib18","volume":"vol. 7","author":"Farzani","year":"2019"},{"key":"10.1016\/j.antiviral.2019.104702_bib21","first-page":"19193","article-title":"Bispecific antibody affords complete post-exposure protection of mice from both Ebola (zaire) and Sudan viruses","volume":"6","author":"Frei","year":"2016","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.antiviral.2019.104702_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/v10060286","article-title":"Post-exposure protection in mice against Sudan virus by a two antibody cocktail","volume":"10","author":"Froude","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104702_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005908","article-title":"A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models","volume":"11","author":"Garrison","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012760","article-title":"Development of a new tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog","volume":"5","author":"Gowen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104702_bib25","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/JVI.00074-09","article-title":"Replication-deficient ebolavirus as a vaccine candidate","volume":"83","author":"Halfmann","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.0708057105","article-title":"Generation of biologically contained Ebola viruses","volume":"105","author":"Halfmann","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2019.104702_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2018.06.013","article-title":"Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice","volume":"157","author":"Hawman","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104702_bib28","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/JVI.03361-12","article-title":"Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus","volume":"87","author":"Herbert","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02076-16","article-title":"Immunization with DNA plasmids coding for crimean-Congo hemorrhagic fever virus capsid and envelope proteins and\/or virus-like particles induces protection and survival in challenged mice","volume":"91","author":"Hinkula","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib30","doi-asserted-by":"crossref","first-page":"13063","DOI":"10.1128\/JVI.01389-10","article-title":"Mice lacking alpha\/beta and gamma interferon receptors are susceptible to Junin virus infection","volume":"84","author":"Kolokoltsova","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004969","article-title":"The ectodomain of glycoprotein from the Candid#1 vaccine strain of Junin virus rendered machupo virus partially attenuated in mice lacking IFN-\u03b1\u03b2\/\u03b3 receptor","volume":"10","author":"Koma","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.02615-15","article-title":"Machupo virus expressing GPC of the Candid#1 vaccine strain of Junin virus is highly attenuated and immunogenic","volume":"90","author":"Koma","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/vbz.2015.1855","article-title":"Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but No protection in STAT1 knockout mice","volume":"15","author":"Kortekaas","year":"2015","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.vetmic.2016.09.009","article-title":"Mouse model for the Rift Valley fever virus MP12 strain infection","volume":"195","author":"Lang","year":"2016","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104702_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00479-17","article-title":"Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice","volume":"91","author":"Lennemann","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1099\/jmm.0.036210-0","article-title":"Lethality and pathogenesis of airborne infection with filoviruses in A129 \u03b1\/\u03b2 -\/- interferon receptor-deficient mice","volume":"61","author":"Lever","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104702_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002309","article-title":"A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection","volume":"7","author":"Lopez-Gil","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib38","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2010.02.018","article-title":"Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR\u2212\/\u2212 mice induced by different DNA vaccination regimens","volume":"28","author":"Lorenzo","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.104702_bib39","first-page":"1","article-title":"Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination","author":"L\u00fcdtke","year":"2017","journal-title":"Sci. Rep. In press"},{"key":"10.1016\/j.antiviral.2019.104702_bib40","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1099\/vir.0.80974-0","article-title":"Evidence for recombination in Crimean-Congo hemorrhagic fever virus","volume":"86","author":"Lukashev","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaa4919","article-title":"Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates","volume":"348","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104702_bib42","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1093\/infdis\/jiv188","article-title":"STAT1-Deficient mice are not an appropriate model for efficacy testing of recombinant vesicular stomatitis virus-based filovirus vaccines","volume":"2","author":"Marzi","year":"2015","journal-title":"J. Infect. Dis. Suppl"},{"key":"10.1016\/j.antiviral.2019.104702_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"Passage history, properties and applicability of the attenuated vaccinia virus strain MVA [Abstammung, eigenschaften und verwendung des attenuierten vaccinia-stammes MVA]","volume":"3","author":"Mayr","year":"1975","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2019.104702_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0092-8674(00)81288-X","article-title":"Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway","volume":"84","author":"Meraz","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.104702_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005656","article-title":"Chimeric mice with competent hematopoietic immunity reproduce key features of severe lassa fever","volume":"12","author":"Oestereich","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104702_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002804","article-title":"Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever","volume":"8","author":"Oestereich","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002407","article-title":"A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection","volume":"7","author":"Pinto","year":"2011","journal-title":"PLoS Pathog."},{"issue":"Suppl. l","key":"10.1016\/j.antiviral.2019.104702_bib48","doi-asserted-by":"crossref","first-page":"S986","DOI":"10.1093\/infdis\/jir335","article-title":"Filovirus infection of STAT-1 knockout mice","volume":"204","author":"Raymond","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib49","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.1038\/s41598-019-44210-6","article-title":"Vesicular stomatitis virus-based vaccine protects mice against crimean-Congo hemorrhagic fever","volume":"9","author":"Rodriguez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104702_bib50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/22221751.2019.1601030","article-title":"Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice","volume":"8","author":"Scholte","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2019.104702_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005296","article-title":"Neuropathogenesis of zika virus in a highly susceptible immunocompetent mouse model after antibody blockade of type I interferon","volume":"11","author":"Smith","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib52","article-title":"Ebola virus makona shows reduced lethality in an immune-deficient mouse model","volume":"jiw145","author":"Smither","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib53","doi-asserted-by":"crossref","first-page":"104573","DOI":"10.1016\/j.antiviral.2019.104573","article-title":"Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine","volume":"170","author":"Spengler","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104702_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104702_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-4-1","article-title":"Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus","volume":"4","author":"Uckun","year":"2004","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib56","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/JVI.74.3.1538-1543.2000","article-title":"The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice","volume":"74","author":"Vialat","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib57","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JVI.06284-11","article-title":"Functional interferon system is required for clearance of lassa virus","volume":"86","author":"Yun","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib58","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1128\/JVI.02948-15","article-title":"Animal model of sensorineural hearing loss associated with lassa virus infection","volume":"90","author":"Yun","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01433-13","article-title":"Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus","volume":"87","author":"Yun","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104702_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jit061","article-title":"Lethal Crimean-Congo hemorrhagic fever virus infection in interferon \u03b1\/\u03b2 receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy","volume":"207","author":"Zivcec","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006628","article-title":"Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge","volume":"12","author":"Zivcec","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104702_bib62","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.3390\/v4123468","article-title":"Development of a murine model for aerosolized ebolavirus infection using a panel of recombinant inbred mice","volume":"4","author":"Zumbrun","year":"2012","journal-title":"Viruses"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219305637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219305637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:45Z","timestamp":1759062765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219305637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":63,"alternative-id":["S0166354219305637"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104702","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104702"}}